Here are five recent financial reports from spine-driven device companies.
Spinal Tech
The Food and Drug Administration granted 26 spine-related 510(k) clearances in December, according to an FDA report.
The Musculoskeletal Transplant Foundation has partnered with CONMED Linvatec, which will market the company's sports medicine allograft tissues worldwide, according to a company news release.
Houston-based Essex Woodlands, a global healthcare growth equity and venture capital firm, has entered into a strategic partnership with Smith & Nephew to fund a spinout of its biologics and clinical therapies division, according to a company news release.
Here are 14 executive moves from spine device companies in 2011.
Advertisement
Synthes, a Swiss spine device company currently in the middle of being acquired by Johnson & Johnson, recently filed suit against three former sales representatives and Stryker for breaching company loyalty, according to a Philadelphia Inquirer news report.
Symmetry Medical, a Warsaw, Ind.-based orthopedic device company, recently closed on its acquisition of the surgical implants business Codman & Shurtleff, according to a Symmetry news release.
Allen Schlein, MD, a Connecticut-based orthopedic surgeon, was recently awarded more than $2 million from Orthopedic Systems for lost royalties on a device for shoulder surgery, according to a report from the San Francisco Chronicle.
Medical and legal bills associated with metal-on-metal hip implants are taking a financial toll on the healthcare system, according to a New York Times report.
Minnesota medical device company KSpine raised $2.5 million that will fund clinical trials for the company's spinal implant to treat scoliosis, according to a Medcity News report.